Firefly Neuroscience
AIFF
23 hedge funds and large institutions have $1.77M invested in Firefly Neuroscience in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
21% more funds holding
Funds holding: 19 → 23 (+4)
5% more capital invested
Capital invested by funds: $1.69M → $1.77M (+$86.8K)
0.43% less ownership
Funds ownership: 5.32% → 4.88% (-0.43%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$465K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$184K |
| 3 |
BlackRock
New York
|
+$50K |
| 4 |
Millennium Management
New York
|
+$31.9K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$16.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
-$89K |
| 2 |
Morgan Stanley
New York
|
-$72.2K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6.34K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$5.54K |
| 5 |
CA
Continuum Advisory
Eagle,
Idaho
|
-$4 |
AIFF Hedge Fund Activity: Q2 2025 in Review
23 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Firefly Neuroscience (AIFF) for Q2 2025, worth a combined $1.77M — up 5.1% from $1.69M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new AIFF positions and 3 closed out — a net gain of 4 holders — while 7 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $465K. The largest seller was FNY Investment Advisers, exiting entirely with an estimated $89K sold.
- 23 institutional investors held Firefly Neuroscience (AIFF) as of Q2 2025, up from 19 in Q1 2025.
- Funds reported $1.77M of Firefly Neuroscience stock for Q2 2025, up 5.1% quarter-over-quarter.
- 7 funds opened new Firefly Neuroscience positions in Q2 2025 and 3 closed out, a net change of +4 holders.
- The largest Firefly Neuroscience buyer in Q2 2025 was UBS Group, an estimated $465K added.
- The largest Firefly Neuroscience seller in Q2 2025 was FNY Investment Advisers, an estimated $89K sold.
Based on aggregated 13F filings for Q2 2025.